Infertility Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Drug Class (Ovulatory Stimulants, Selective Estrogen Receptor Modulators (SERMs), Biguanides, Dopamine Agonists, Tricyclic Antidepressants, Others); Gender (Male, Female); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography
Report Code: TIPRE00004428 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Medications are a regular and normal part of infertility treatments as well as in-vitro fertilization (IVF) procedures. Infertility drugs are used to prepare the body for treatment to increase the probability of health egg release from the ovaries. Infertility can result from problems in males and females. Most doctors recommend seeking treatment if a woman cannot get pregnant or continues to have miscarriages after trying to conceive for 12 months or longer.
MARKET DYNAMICS
The infertility drugs market is anticipated to grow in the forecast, owing to changing lifestyle patterns and technological advancements in human reproductive research. In addition, development of novel drugs by market players from emerging nations is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Infertility Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of infertility drugs market with detailed market segmentation by drug class, gender, distribution channel and geography. The global infertility drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading infertility drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global infertility drugs market is segmented on the basis of by drug class, gender and distribution channel. Based on drug class, the market is segmented as, ovulatory stimulants, selective estrogen receptor modulators (SERMS), biguanides, dopamine agonists, tricyclic antidepressants, and others. On the basis of gender, the global infertility drugs market is segmented into male and female. Based on distribution channel, the market is segmented in to hospital pharmacies, retail pharmacies, and online pharmacies.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infertility drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The infertility drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting infertility drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the infertility drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the infertility drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from infertility drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for infertility drugs market in the global market. Below mentioned is the list of few companies engaged in the infertility drugs market.
The report also includes the profiles of key infertility drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Medications are a regular and normal part of infertility treatments as well as in-vitro fertilization (IVF) procedures. Infertility drugs are used to prepare the body for treatment to increase the probability of health egg release from the ovaries. Infertility can result from problems in males and females. Most doctors recommend seeking treatment if a woman cannot get pregnant or continues to have miscarriages after trying to conceive for 12 months or longer.
MARKET DYNAMICS
The infertility drugs market is anticipated to grow in the forecast, owing to changing lifestyle patterns and technological advancements in human reproductive research. In addition, development of novel drugs by market players from emerging nations is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Infertility Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of infertility drugs market with detailed market segmentation by drug class, gender, distribution channel and geography. The global infertility drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading infertility drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global infertility drugs market is segmented on the basis of by drug class, gender and distribution channel. Based on drug class, the market is segmented as, ovulatory stimulants, selective estrogen receptor modulators (SERMS), biguanides, dopamine agonists, tricyclic antidepressants, and others. On the basis of gender, the global infertility drugs market is segmented into male and female. Based on distribution channel, the market is segmented in to hospital pharmacies, retail pharmacies, and online pharmacies.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infertility drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The infertility drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting infertility drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the infertility drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the infertility drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from infertility drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for infertility drugs market in the global market. Below mentioned is the list of few companies engaged in the infertility drugs market.
The report also includes the profiles of key infertility drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- F. Hoffmann-La Roche Ltd
- Merck KGaA
- Eli Lilly and Company
- Bayer AG
- Novartis AG
- Ferring B.V.
- COOPER PHARMA LIMITED
- senechio Pharma Pvt. Ltd.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Infertility Drugs Market - By Drug Class
1.3.2 Infertility Drugs Market - By Gender
1.3.3 Infertility Drugs Market - By Distribution Channel
1.3.4 Infertility Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. INFERTILITY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFERTILITY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. INFERTILITY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFERTILITY DRUGS - GLOBAL MARKET OVERVIEW
6.2. INFERTILITY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INFERTILITY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. OVULATORY STIMULANTS
7.3.1. Overview
7.3.2. Ovulatory Stimulants Market Forecast and Analysis
7.4. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS)
7.4.1. Overview
7.4.2. Selective Estrogen Receptor Modulators (SERMs) Market Forecast and Analysis
7.5. BIGUANIDES
7.5.1. Overview
7.5.2. Biguanides Market Forecast and Analysis
7.6. DOPAMINE AGONISTS
7.6.1. Overview
7.6.2. Dopamine Agonists Market Forecast and Analysis
7.7. TRICYCLIC ANTIDEPRESSANTS
7.7.1. Overview
7.7.2. Tricyclic Antidepressants Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. INFERTILITY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - GENDER
8.1. OVERVIEW
8.2. GENDER MARKET FORECASTS AND ANALYSIS
8.3. MALE
8.3.1. Overview
8.3.2. Male Market Forecast and Analysis
8.4. FEMALE
8.4.1. Overview
8.4.2. Female Market Forecast and Analysis
9. INFERTILITY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. INFERTILITY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Infertility Drugs Market Overview
10.1.2 North America Infertility Drugs Market Forecasts and Analysis
10.1.3 North America Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.1.4 North America Infertility Drugs Market Forecasts and Analysis - By Gender
10.1.5 North America Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Infertility Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Infertility Drugs Market
10.1.6.1.1 United States Infertility Drugs Market by Drug Class
10.1.6.1.2 United States Infertility Drugs Market by Gender
10.1.6.1.3 United States Infertility Drugs Market by Distribution Channel
10.1.6.2 Canada Infertility Drugs Market
10.1.6.2.1 Canada Infertility Drugs Market by Drug Class
10.1.6.2.2 Canada Infertility Drugs Market by Gender
10.1.6.2.3 Canada Infertility Drugs Market by Distribution Channel
10.1.6.3 Mexico Infertility Drugs Market
10.1.6.3.1 Mexico Infertility Drugs Market by Drug Class
10.1.6.3.2 Mexico Infertility Drugs Market by Gender
10.1.6.3.3 Mexico Infertility Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Infertility Drugs Market Overview
10.2.2 Europe Infertility Drugs Market Forecasts and Analysis
10.2.3 Europe Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Infertility Drugs Market Forecasts and Analysis - By Gender
10.2.5 Europe Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Infertility Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Infertility Drugs Market
10.2.6.1.1 Germany Infertility Drugs Market by Drug Class
10.2.6.1.2 Germany Infertility Drugs Market by Gender
10.2.6.1.3 Germany Infertility Drugs Market by Distribution Channel
10.2.6.2 France Infertility Drugs Market
10.2.6.2.1 France Infertility Drugs Market by Drug Class
10.2.6.2.2 France Infertility Drugs Market by Gender
10.2.6.2.3 France Infertility Drugs Market by Distribution Channel
10.2.6.3 Italy Infertility Drugs Market
10.2.6.3.1 Italy Infertility Drugs Market by Drug Class
10.2.6.3.2 Italy Infertility Drugs Market by Gender
10.2.6.3.3 Italy Infertility Drugs Market by Distribution Channel
10.2.6.4 Spain Infertility Drugs Market
10.2.6.4.1 Spain Infertility Drugs Market by Drug Class
10.2.6.4.2 Spain Infertility Drugs Market by Gender
10.2.6.4.3 Spain Infertility Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Infertility Drugs Market
10.2.6.5.1 United Kingdom Infertility Drugs Market by Drug Class
10.2.6.5.2 United Kingdom Infertility Drugs Market by Gender
10.2.6.5.3 United Kingdom Infertility Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Infertility Drugs Market Overview
10.3.2 Asia-Pacific Infertility Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Infertility Drugs Market Forecasts and Analysis - By Gender
10.3.5 Asia-Pacific Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Infertility Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Infertility Drugs Market
10.3.6.1.1 Australia Infertility Drugs Market by Drug Class
10.3.6.1.2 Australia Infertility Drugs Market by Gender
10.3.6.1.3 Australia Infertility Drugs Market by Distribution Channel
10.3.6.2 China Infertility Drugs Market
10.3.6.2.1 China Infertility Drugs Market by Drug Class
10.3.6.2.2 China Infertility Drugs Market by Gender
10.3.6.2.3 China Infertility Drugs Market by Distribution Channel
10.3.6.3 India Infertility Drugs Market
10.3.6.3.1 India Infertility Drugs Market by Drug Class
10.3.6.3.2 India Infertility Drugs Market by Gender
10.3.6.3.3 India Infertility Drugs Market by Distribution Channel
10.3.6.4 Japan Infertility Drugs Market
10.3.6.4.1 Japan Infertility Drugs Market by Drug Class
10.3.6.4.2 Japan Infertility Drugs Market by Gender
10.3.6.4.3 Japan Infertility Drugs Market by Distribution Channel
10.3.6.5 South Korea Infertility Drugs Market
10.3.6.5.1 South Korea Infertility Drugs Market by Drug Class
10.3.6.5.2 South Korea Infertility Drugs Market by Gender
10.3.6.5.3 South Korea Infertility Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Infertility Drugs Market Overview
10.4.2 Middle East and Africa Infertility Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Infertility Drugs Market Forecasts and Analysis - By Gender
10.4.5 Middle East and Africa Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Infertility Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Infertility Drugs Market
10.4.6.1.1 South Africa Infertility Drugs Market by Drug Class
10.4.6.1.2 South Africa Infertility Drugs Market by Gender
10.4.6.1.3 South Africa Infertility Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Infertility Drugs Market
10.4.6.2.1 Saudi Arabia Infertility Drugs Market by Drug Class
10.4.6.2.2 Saudi Arabia Infertility Drugs Market by Gender
10.4.6.2.3 Saudi Arabia Infertility Drugs Market by Distribution Channel
10.4.6.3 U.A.E Infertility Drugs Market
10.4.6.3.1 U.A.E Infertility Drugs Market by Drug Class
10.4.6.3.2 U.A.E Infertility Drugs Market by Gender
10.4.6.3.3 U.A.E Infertility Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Infertility Drugs Market Overview
10.5.2 South and Central America Infertility Drugs Market Forecasts and Analysis
10.5.3 South and Central America Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Infertility Drugs Market Forecasts and Analysis - By Gender
10.5.5 South and Central America Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Infertility Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Infertility Drugs Market
10.5.6.1.1 Brazil Infertility Drugs Market by Drug Class
10.5.6.1.2 Brazil Infertility Drugs Market by Gender
10.5.6.1.3 Brazil Infertility Drugs Market by Distribution Channel
10.5.6.2 Argentina Infertility Drugs Market
10.5.6.2.1 Argentina Infertility Drugs Market by Drug Class
10.5.6.2.2 Argentina Infertility Drugs Market by Gender
10.5.6.2.3 Argentina Infertility Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INFERTILITY DRUGS MARKET, KEY COMPANY PROFILES
12.1. PFIZER, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK KGAA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BAYER AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. FERRING B.V.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. COOPER PHARMA LIMITED
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SENECHIO PHARMA PVT. LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Infertility Drugs Market - By Drug Class
1.3.2 Infertility Drugs Market - By Gender
1.3.3 Infertility Drugs Market - By Distribution Channel
1.3.4 Infertility Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. INFERTILITY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFERTILITY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. INFERTILITY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFERTILITY DRUGS - GLOBAL MARKET OVERVIEW
6.2. INFERTILITY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INFERTILITY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. OVULATORY STIMULANTS
7.3.1. Overview
7.3.2. Ovulatory Stimulants Market Forecast and Analysis
7.4. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS)
7.4.1. Overview
7.4.2. Selective Estrogen Receptor Modulators (SERMs) Market Forecast and Analysis
7.5. BIGUANIDES
7.5.1. Overview
7.5.2. Biguanides Market Forecast and Analysis
7.6. DOPAMINE AGONISTS
7.6.1. Overview
7.6.2. Dopamine Agonists Market Forecast and Analysis
7.7. TRICYCLIC ANTIDEPRESSANTS
7.7.1. Overview
7.7.2. Tricyclic Antidepressants Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. INFERTILITY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - GENDER
8.1. OVERVIEW
8.2. GENDER MARKET FORECASTS AND ANALYSIS
8.3. MALE
8.3.1. Overview
8.3.2. Male Market Forecast and Analysis
8.4. FEMALE
8.4.1. Overview
8.4.2. Female Market Forecast and Analysis
9. INFERTILITY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. INFERTILITY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Infertility Drugs Market Overview
10.1.2 North America Infertility Drugs Market Forecasts and Analysis
10.1.3 North America Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.1.4 North America Infertility Drugs Market Forecasts and Analysis - By Gender
10.1.5 North America Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Infertility Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Infertility Drugs Market
10.1.6.1.1 United States Infertility Drugs Market by Drug Class
10.1.6.1.2 United States Infertility Drugs Market by Gender
10.1.6.1.3 United States Infertility Drugs Market by Distribution Channel
10.1.6.2 Canada Infertility Drugs Market
10.1.6.2.1 Canada Infertility Drugs Market by Drug Class
10.1.6.2.2 Canada Infertility Drugs Market by Gender
10.1.6.2.3 Canada Infertility Drugs Market by Distribution Channel
10.1.6.3 Mexico Infertility Drugs Market
10.1.6.3.1 Mexico Infertility Drugs Market by Drug Class
10.1.6.3.2 Mexico Infertility Drugs Market by Gender
10.1.6.3.3 Mexico Infertility Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Infertility Drugs Market Overview
10.2.2 Europe Infertility Drugs Market Forecasts and Analysis
10.2.3 Europe Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Infertility Drugs Market Forecasts and Analysis - By Gender
10.2.5 Europe Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Infertility Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Infertility Drugs Market
10.2.6.1.1 Germany Infertility Drugs Market by Drug Class
10.2.6.1.2 Germany Infertility Drugs Market by Gender
10.2.6.1.3 Germany Infertility Drugs Market by Distribution Channel
10.2.6.2 France Infertility Drugs Market
10.2.6.2.1 France Infertility Drugs Market by Drug Class
10.2.6.2.2 France Infertility Drugs Market by Gender
10.2.6.2.3 France Infertility Drugs Market by Distribution Channel
10.2.6.3 Italy Infertility Drugs Market
10.2.6.3.1 Italy Infertility Drugs Market by Drug Class
10.2.6.3.2 Italy Infertility Drugs Market by Gender
10.2.6.3.3 Italy Infertility Drugs Market by Distribution Channel
10.2.6.4 Spain Infertility Drugs Market
10.2.6.4.1 Spain Infertility Drugs Market by Drug Class
10.2.6.4.2 Spain Infertility Drugs Market by Gender
10.2.6.4.3 Spain Infertility Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Infertility Drugs Market
10.2.6.5.1 United Kingdom Infertility Drugs Market by Drug Class
10.2.6.5.2 United Kingdom Infertility Drugs Market by Gender
10.2.6.5.3 United Kingdom Infertility Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Infertility Drugs Market Overview
10.3.2 Asia-Pacific Infertility Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Infertility Drugs Market Forecasts and Analysis - By Gender
10.3.5 Asia-Pacific Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Infertility Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Infertility Drugs Market
10.3.6.1.1 Australia Infertility Drugs Market by Drug Class
10.3.6.1.2 Australia Infertility Drugs Market by Gender
10.3.6.1.3 Australia Infertility Drugs Market by Distribution Channel
10.3.6.2 China Infertility Drugs Market
10.3.6.2.1 China Infertility Drugs Market by Drug Class
10.3.6.2.2 China Infertility Drugs Market by Gender
10.3.6.2.3 China Infertility Drugs Market by Distribution Channel
10.3.6.3 India Infertility Drugs Market
10.3.6.3.1 India Infertility Drugs Market by Drug Class
10.3.6.3.2 India Infertility Drugs Market by Gender
10.3.6.3.3 India Infertility Drugs Market by Distribution Channel
10.3.6.4 Japan Infertility Drugs Market
10.3.6.4.1 Japan Infertility Drugs Market by Drug Class
10.3.6.4.2 Japan Infertility Drugs Market by Gender
10.3.6.4.3 Japan Infertility Drugs Market by Distribution Channel
10.3.6.5 South Korea Infertility Drugs Market
10.3.6.5.1 South Korea Infertility Drugs Market by Drug Class
10.3.6.5.2 South Korea Infertility Drugs Market by Gender
10.3.6.5.3 South Korea Infertility Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Infertility Drugs Market Overview
10.4.2 Middle East and Africa Infertility Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Infertility Drugs Market Forecasts and Analysis - By Gender
10.4.5 Middle East and Africa Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Infertility Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Infertility Drugs Market
10.4.6.1.1 South Africa Infertility Drugs Market by Drug Class
10.4.6.1.2 South Africa Infertility Drugs Market by Gender
10.4.6.1.3 South Africa Infertility Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Infertility Drugs Market
10.4.6.2.1 Saudi Arabia Infertility Drugs Market by Drug Class
10.4.6.2.2 Saudi Arabia Infertility Drugs Market by Gender
10.4.6.2.3 Saudi Arabia Infertility Drugs Market by Distribution Channel
10.4.6.3 U.A.E Infertility Drugs Market
10.4.6.3.1 U.A.E Infertility Drugs Market by Drug Class
10.4.6.3.2 U.A.E Infertility Drugs Market by Gender
10.4.6.3.3 U.A.E Infertility Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Infertility Drugs Market Overview
10.5.2 South and Central America Infertility Drugs Market Forecasts and Analysis
10.5.3 South and Central America Infertility Drugs Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Infertility Drugs Market Forecasts and Analysis - By Gender
10.5.5 South and Central America Infertility Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Infertility Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Infertility Drugs Market
10.5.6.1.1 Brazil Infertility Drugs Market by Drug Class
10.5.6.1.2 Brazil Infertility Drugs Market by Gender
10.5.6.1.3 Brazil Infertility Drugs Market by Distribution Channel
10.5.6.2 Argentina Infertility Drugs Market
10.5.6.2.1 Argentina Infertility Drugs Market by Drug Class
10.5.6.2.2 Argentina Infertility Drugs Market by Gender
10.5.6.2.3 Argentina Infertility Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INFERTILITY DRUGS MARKET, KEY COMPANY PROFILES
12.1. PFIZER, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK KGAA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BAYER AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. FERRING B.V.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. COOPER PHARMA LIMITED
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SENECHIO PHARMA PVT. LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Pfizer, Inc.
2. Takeda Pharmaceutical Company Limited
3. F. Hoffmann-La Roche Ltd
4. Merck KGaA
5. Eli Lilly and Company
6. Bayer AG
7. Novartis AG
8. Ferring B. V.
9. COOPER PHARMA LIMITED
10. senechio Pharma Pvt. Ltd.
1. Pfizer, Inc.
2. Takeda Pharmaceutical Company Limited
3. F. Hoffmann-La Roche Ltd
4. Merck KGaA
5. Eli Lilly and Company
6. Bayer AG
7. Novartis AG
8. Ferring B. V.
9. COOPER PHARMA LIMITED
10. senechio Pharma Pvt. Ltd.